Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H40O4 |
Molecular Weight | 392.572 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
InChI
InChIKey=RUDATBOHQWOJDD-UZVSRGJWSA-N
InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1
Molecular Formula | C24H40O4 |
Molecular Weight | 392.572 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 10 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:06:22 UTC 2023
by
admin
on
Fri Dec 15 15:06:22 UTC 2023
|
Record UNII |
724L30Y2QR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000006801
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
242607
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
55390
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
LOINC |
55159-8
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
191204
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
NDF-RT |
N0000175802
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
WHO-VATC |
QA05AA02
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
22187
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/17/1878
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
636718
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
NCI_THESAURUS |
C2089
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
LIVERTOX |
NBK548309
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
WHO-ATC |
A05AA02
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
||
|
NCI_THESAURUS |
C29703
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Ursodiol
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
31401
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
204-879-3
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
100000092107
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
CHEMBL1551
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
DTXSID6023731
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
683769
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
SUB11389MIG
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
D014580
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
724L30Y2QR
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
128-13-2
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
62427
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
ALTERNATIVE | |||
|
m11344
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | Merck Index | ||
|
78604
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
C1818
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
1707806
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
724L30Y2QR
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
DB01586
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
7104
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
Z-35
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
9907
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
2797
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
4920
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
11065
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY | |||
|
URSODIOL
Created by
admin on Fri Dec 15 15:06:22 UTC 2023 , Edited by admin on Fri Dec 15 15:06:22 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> AGONIST |
When bound to bile acids, FXR repressed transcription of the gene encoding cholesterol 7α-hydroxylase, which is the rate-limiting enzyme in bile acid synthesis, and activated the gene encoding intestinal bile acid?binding protein, which is a candidate bile acid transporter.
AGONIST
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
FECAL
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
PARENT -> METABOLITE ACTIVE |
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
BILE
|
||
|
METABOLITE -> PARENT |
BILE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |